Hormonal management of premenstrual syndrome
Tài liệu tham khảo
Panay, 2005, Premenstrual syndrome: making sense of the options, Pulse, 65, 50
Halbreich, 2003, The prevalence, impairment, impact and burden of premenstrual dysphoric disorder (PMS/PMDD), Psychoneuroendocrinology, 28, 1, 10.1016/S0306-4530(03)00098-2
Backstrom, 2003, The role of hormones and hormonal treatments in premenstrual syndrome, CNS Drugs, 17, 325, 10.2165/00023210-200317050-00003
Hussain, 1992, Buserilin in premenstrual syndrome, J Gynaecol Endocrinol, 6, 57, 10.3109/09513599209081007
Hammarback, 1985, Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen–progestogen postmenopausal replacement treatment, Acta Obstet Gynecol Scand, 64, 393, 10.3109/00016348509155154
Rapkin, 1997, Progesterone metabolite allopregnanolone in women with premenstrual syndrome, Obstet Gynecol, 90, 709, 10.1016/S0029-7844(97)00417-1
Brambilla, 2003, GABAergic dysfunction in mood disorders, Mol Psychiatry, 8, 721, 10.1038/sj.mp.4001362
Bicikova, 1998, Allopregnanolone in women with premenstrual syndrome, Horm Metab Res, 30, 227, 10.1055/s-2007-978871
Genazzani, 2006, Neuroendocrine correlates of premenstrual syndrome, Gynaecol Forum, 11, 23
Beauchamp, 2000, Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats, Pharmacol Biochem Behav, 67, 29, 10.1016/S0091-3057(00)00299-9
Backstrom, 2006, Hormones and premenstrual syndrome, Gynaecol Forum, 11, 20
Halbreich, 2006, Diagnosis of premenstrual syndrome, Gynaecol Forum, 11, 5
Ismail, 2006
Ford, 2006, Progesterone for premenstrual syndrome, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003415.pub2
Magill, 1995, Investigations of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome, Br J Gen Pract, 45, 589
Veneslow, 1996, Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration, J Psychosom Obstet Gynaecol, 17, 29, 10.3109/01674829609025661
Wyatt, 2001, Efficacy of progesterone and progestogens in the management of premenstrual syndrome: systematic review, BMJ, 323, 776, 10.1136/bmj.323.7316.776
Watson, 1989, Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone, Lancet, 2, 730, 10.1016/S0140-6736(89)90784-8
De Ligieres, 1986, Prevention of premenstrual migraine by percutaneous oestradiol, BMJ, 293, 1540, 10.1136/bmj.293.6561.1540
Magos, 1986, Treatment of premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo controlled study, BMJ, 292, 1629, 10.1136/bmj.292.6536.1629
Rapkin, 2003, A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder, Psychoneuroendocrinology, 28, 39, 10.1016/S0306-4530(03)00096-9
Freeman, 2001, Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder, J Womens Health Gend Based Med, 10, 561, 10.1089/15246090152543148
Dickerson, 2002, Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drosperinone, J Reprod Med, 47, 985
Wyatt, 2004, The effectiveness of GnRHa with or without ‘addback’ therapy in treating premenstrual syndrome: a meta analysis, Br J Obstet Gynaecol, 111, 585, 10.1111/j.1471-0528.2004.00135.x
Hahn, 1995, A randomised, placebo-controlled crossover trail of danazol for the treatment of premenstrual syndrome, Psychoneuroendocrinology, 20, 193, 10.1016/0306-4530(94)00053-D
Wetzig, 1994, Mastalgia: a 3-year Australian study, Aust N Z J Surg, 64, 329, 10.1111/j.1445-2197.1994.tb02221.x
O'Brien, 1999, Randomised controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol, Am J Obstet Gynecol, 180, 18, 10.1016/S0002-9378(99)70142-0
Kaleli, 2001, Symptomatic treatment of premenstrual mastalgia in premenstrual women with lisuride maleate: a double-blind placebo-controlled randomised study, Fertil Steril, 75, 718, 10.1016/S0015-0282(01)01668-5
Benedek-Jaszmann, 1976, Premenstrual tension and functional infertility: aetiology and treatment, Lancet, 1, 1095, 10.1016/S0140-6736(76)90062-3
Graham, 1978, Prolactin suppression in the treatment of premenstrual tension syndrome, Med J Aust, 2, 18, 10.5694/j.1326-5377.1978.tb77381.x
O'Brien, 1979, Treatment of premenstrual syndrome by spironolactone, Br J Obstet Gynaecol, 86, 142, 10.1111/j.1471-0528.1979.tb10582.x
Aslaksen, 1991, Spironolactone in the treatment of premenstrual tension: a double-blind study of spironolactone versus bendroflumethiaxide and placebo, Curr Ther Res, 49, 120
Vellacott, 1987, A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome, Curr Med Res Opin, 10, 450, 10.1185/03007998709112403
Hellberg, 1991, Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate, Int J Gynaecol Obstet, 34, 243, 10.1016/0020-7292(91)90357-B
Wang, 1995, Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study, Acta Obstet Gynecol Scand, 74, 803, 10.3109/00016349509021201
Burnet, 1991, Premenstrual syndrome and spironolactone, Aust N Z J Obstet Gynaecol, 31, 366, 10.1111/j.1479-828X.1991.tb02824.x
Dimmock, 2000, Efficacy of selective serotonin re-uptake inhibitors in premenstrual syndrome: a systematic review, Lancet, 356, 1131, 10.1016/S0140-6736(00)02754-9
Cohen, 2002, Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo- controlled, clinical trial using computerized diaries, Obstet Gynecol, 100, 435, 10.1016/S0029-7844(02)02166-X
Halbreich, 2002, Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder, Obstet Gynecol, 100, 1219, 10.1016/S0029-7844(02)02326-8
Wikander, 1998, Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phase more effective than continuous medication throughout the menstrual cycle?, J Clin Psychopharmacol, 18, 390, 10.1097/00004714-199810000-00007
Pearlstein, 1997, Comparison of fluoxetine, bupropion and placebo in the treatment of premenstrual dysphoric disorder, J Clin Psychopharmacol, 17, 261, 10.1097/00004714-199708000-00004
Freeman, 1999, Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomised controlled trial, Arch Gen Psychiatry, 56, 932, 10.1001/archpsyc.56.10.932
De Souza, 2000, A synergistic effect of a daily supplement for one month of 200 mg magnesium plus 50 mg Vit B6 for the relief of anxiety related premenstrual symptoms: a randomised, double blind, crossover study, J Women's Health Gend Based Med, 9, 131, 10.1089/152460900318623
Thys-Jacobs, 1998, Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group, Am J Obstet Gynecol, 179, 444, 10.1016/S0002-9378(98)70377-1
Schellenberg, 2001, Treatment for the premenstrual syndrome with Agnus castus fruit extract: prospective randomised placebo controlled study, BMJ, 322, 134, 10.1136/bmj.322.7279.134
Bibi, 1995, The effects of aerobic exercise on premenstrual syndrome symptoms, Dissert Abst Int, 56, 6678